Moving beyond the current limits of data analysis in longevity and healthy lifespan studies

Wilson Wen Bin Goh*, Subhash Thalappilly, Guillaume Thibault

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Living longer with sustainable quality of life is becoming increasingly important in aging populations. Understanding associative biological mechanisms have proven daunting, because of multigenicity and population heterogeneity. Although Big Data and Artificial Intelligence (AI) could help, naïve adoption is ill advised. We hold the view that model organisms are better suited for big-data analytics but might lack relevance because they do not immediately reflect the human condition. Resolving this hurdle and bridging the human–model organism gap will require some finesse. This includes improving signal:noise ratios by appropriate contextualization of high-throughput data, establishing consistency across multiple high-throughput platforms, and adopting supporting technologies that provide useful in silico and in vivo validation strategies. Understanding the complex phenotypes of aging and longevity requires careful examination and appropriate contextualization of multi-omic big data, strategic use of new technology, and a continued focus on animal models.

Original languageEnglish
Pages (from-to)2273-2285
Number of pages13
JournalDrug Discovery Today
Volume24
Issue number12
DOIs
Publication statusPublished - Dec 2019
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2019 Elsevier Ltd

ASJC Scopus Subject Areas

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Moving beyond the current limits of data analysis in longevity and healthy lifespan studies'. Together they form a unique fingerprint.

Cite this